CLR-124

N/A

Report date: 2025/11/24 11:49:33

Base Information

Drug NameCLR-124
Drug Alias NameLIGHTCLR-124[124I]NM-404NM-404-[124I][124I]CLR-1404 +[6] 
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Iodine > 124I +[5] 
Mechanisms of ActionSerine/threonine-protein kinase AKT1 inhibitorsPositron-emission tomography enhancers
TargetsSerine/threonine-protein kinase AKT1
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of MichiganCellectar Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Wisconsin-MadisonCellectar Biosciences Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A